Literature DB >> 29688923

When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.

Jonathan H Chow1, Samuel M Galvagno1, Kenichi A Tanaka2, Michael A Mazzeffi2, Zackary Chancer1, Reney Henderson2, Michael T McCurdy3.   

Abstract

Angiotensin (AT) II is an endogenous hormone that acts on venous and arterial smooth muscle to cause vasoconstriction. Recent trials have sparked great interest in its ability to be used as a vasopressor for catecholamine-refractory hypotension. Herein, we describe the successful use of AT II in a patient with a colonic perforation with septic shock refractory to conventional treatment. After AT II initiation, there was an immediate reduction in catecholamine requirement, and the patient survived.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29688923     DOI: 10.1213/XAA.0000000000000775

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  5 in total

1.  A Multicenter Observational Cohort Study of Angiotensin II in Shock.

Authors:  Susan E Smith; Andrea S Newsome; Yanglin Guo; Jason Hecht; Michael T McCurdy; Michael A Mazzeffi; Jonathan H Chow; Shravan Kethireddy
Journal:  J Intensive Care Med       Date:  2020-11-24       Impact factor: 3.510

2.  Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.

Authors:  Albert D Bui; Scott A Helgeson; Pramod K Guru; Devang K Sanghavi
Journal:  BMJ Case Rep       Date:  2020-06-28

3.  Angiotensin II Use in Refractory Multisystem Shock: A Case Report.

Authors:  Mohamed Ahmed; Saba Habis; Ahmed Mahmoud; Cedric Rutland; Rasha Saeed
Journal:  Cureus       Date:  2018-11-30

4.  A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.

Authors:  T G Coulson; L F Miles; A Serpa Neto; D Pilcher; L Weinberg; G Landoni; A Zarbock; R Bellomo
Journal:  Anaesthesia       Date:  2022-09       Impact factor: 12.893

5.  Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.

Authors:  Patrick M Wieruszewski; Erica D Wittwer; Kianoush B Kashani; Daniel R Brown; Simona O Butler; Angela M Clark; Craig J Cooper; Danielle L Davison; Ognjen Gajic; Kyle J Gunnerson; Rachel Tendler; Kristin C Mara; Erin F Barreto
Journal:  Chest       Date:  2020-08-31       Impact factor: 9.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.